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The neural cell adhesion molecule L1 mediates the axon out-
growth, adhesion, and fasciculation necessary for proper devel-
opment of synaptic connections. Mutations of human L1 cause an
X-linked mental retardation syndrome termed CRASH (corpus
callosum hypoplasia, retardation, aphasia, spastic paraplegia, and
hydrocephalus), and L1 knock-out mice display defects in neuro-
nal process extension resembling the CRASH phenotype. Little is
known about the biochemical or cellular mechanism by which
L1 performs neuronal functions. Here it is demonstrated that
clustering of L1 with antibodies or L1 protein in rodent B35
neuroblastoma and cerebellar neuron cultures induced the
phosphorylation/activation of the mitogen-activated protein
kinases (MAPKs) and extracellular signal-regulated kinases
1 and 2. MAPK activation was essential for L1-dependent
neurite outgrowth, because chemical inhibitors [2-(29-amino-
39-methoxyphenyl)-oxanaphthalen-4-one and 1,4-diamino-2,3-
dicyano-1,4-bis(2-aminophenylthio)butadiene] of the MAPK ki-
nase MEK strongly suppressed neurite outgrowth by cerebellar
neurons on L1. The nonreceptor tyrosine kinase pp60c-src was
required for L1-triggered MAPK phosphorylation, as shown in
src-minus cerebellar neurons and by expression of the kinase-
inactive mutant Src(K295M) in B35 neuroblastoma cells. Phos-
phatidylinositol 3-kinase (PI3-kinase) and the small GTPase
p21rac were identified as signaling intermediates to MAPK by
phosphoinositide and Rac–GTP assays and expression of in-
hibitory mutants. Antibody-induced endocytosis of L1, visual-
ized by immunofluorescence staining and confocal microscopy
of B35 cells, was blocked by expression of kinase-inactive
Src(K295M) and dominant-negative dynamin(K44A) but not by
inhibitors of MEK or PI3-kinase. Dynamin(K44A) also inhibited
L1 antibody-triggered MAPK phosphorylation. This study sup-
ports a model in which pp60c-src regulates dynamin-mediated
endocytosis of L1 as an essential step in MAPK-dependent
neurite outgrowth on an L1 substrate.
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The cell adhesion molecule L1 functions broadly in regulating the
growth of axons in developing neurons and in fostering learning
in the adult brain (Persohn and Schachner, 1990; Scholey et al.,
1993; Luthi et al., 1994). L1 is localized in the plasmalemma of
growth cones and processes of developing neurons, on axons of
mature nonmyelinated neurons, and in Schwann cells, astrocytes,
and some hematopoietic cells (for review, see Schmid and Man-
ess, 2000). L1 knock-out mice show axon guidance errors in the
corticospinal tract (Cohen et al., 1997) and corpus callosum
(Demyanenko et al., 1999), misoriented dendrites of cortical
pyramidal cells (Demyanenko et al., 1999), degeneration of sen-
sory axons (Haney et al., 1999), and enlarged ventricles (Dahme
et al., 1997; Demyanenko et al., 1999). Many of these features are
present in humans with the X-linked mental retardation syn-
drome termed CRASH (corpus callosum hypoplasia, retardation,
aphasia, spastic paraplegia, and hydrocephalus), resulting from L1
gene mutations (Fransen et al., 1997).
Little is known about the mechanism by which L1 directs
axonal growth or guidance, but the structural features of L1
suggest that it may differ from that used by other classes of
receptors to stimulate neurite outgrowth. The L1 extracellular
region mediates homophilic (L1–L1) and heterophilic binding via
its six immunoglobulin-like and five fibronectin type III domains
(Appel et al., 1993; Zhao et al., 1998). Its short cytoplasmic region
of 110 amino acids lacks a tyrosine kinase domain but contains an
actin-interaction domain (Dahlin-Huppe et al., 1997), an ankyrin-
binding region (Davis and Bennett, 1994), and a neuronal-specific
sequence, RSLE, which targets L1 to axons (Kamiguchi and
Lemmon, 1998). This motif is also involved in binding adaptor
protein 2, a clathrin adaptor, which enables L1 to be internalized
in growth cones via receptor-mediated endocytosis (Kamiguchi
et al., 1998). It is not known whether endocytosis of L1 plays any
role in the biological functions of L1 or merely directs L1 to
intracellular pathways for degradation.
A requirement for the nonreceptor tyrosine kinase pp60c-src in
L1-mediated neurite outgrowth has been identified in src-minus
neurons (Ignelzi et al., 1994), but how pp60c-src regulates neurite
growth on L1 is not known. pp60c-src is tethered by N-terminal
myristylation to the cytoplasmic face of the plasma membrane
and interacts functionally with a variety of receptor types (Man-
ess et al., 1996). On the basis of the recent finding that pp60c-src
is required for endocytosis and signaling of the b-adrenergic
receptor (Ahn et al., 1999), we have investigated the hypothesis
that pp60c-src regulates the internalization of L1 as a critical
determinant of L1-mediated neurite outgrowth. Like the
b-adrenergic receptor, L1 clustering activates mitogen-activated
protein kinases (MAPKs) in neuronal cells (Schmid et al., 1997;
Schaefer et al., 1999), but it is not known whether MAPK has a
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role in neurite outgrowth or other physiological functions of L1.
L1 triggering also modulates intracellular levels of phosphoi-
nositides, pH, and Ca21 (Schuch et al., 1989; von Bohlen und
Halbach et al., 1992) and activates tyrosine phosphatases in
growth cones (Atashi et al., 1992; Klinz et al., 1995), suggesting
that an array of signaling intermediates may coordinate the com-
plex intracellular program that allows growth cones to navigate
through the developing brain and form synaptic connections.
Here we demonstrate that MAPK activation triggered by L1 in
neuronal cells is required for neurite outgrowth on L1 and is
mediated via pp60c-src and the small GTPase p21rac and phospha-
tidylinositol 3-kinase (PI3-kinase). Furthermore, it is shown that
pp60c-src functions by controlling dynamin-mediated endocytosis
of L1 as an essential step in MAPK activation. This L1 pathway
has the potential to regulate both actin cytoskeletal dynamics in
growth cones and gene expression in the nucleus, events that may
coordinate to regulate the growth and navigation of neuronal
processes.
MATERIALS AND METHODS
Antibodies and plasmids. Antibodies used in this research were mouse
monoclonal antibody Neuro4 against the L1 extracellular region (the gift
of John Hemperly, Becton Dickinson); monoclonal antibody HA.11
directed against the hemagglutinin (HA)-epitope tag (Babco, Richmond,
CA); anti-active MAPK polyclonal antibody (Promega, Madison, WI)
specific for dually phosphorylated, activated MAPK; extracellular signal-
regulated kinase 1 (ERK1) polyclonal antibody K-23 and Raf-1 and
B-Raf antibodies (Santa Cruz Biotechnology, Santa Cruz, CA); and
anti-active p38 antibody (New England Biolabs, Beverly, MA). The
following cDNAs were subcloned into the vector pcDNA3 for expression
in B35 neuroblastoma cells: Fak-related nonkinase (FRNK) and
Fak(397F) (Michael Schaller, University of North Carolina, Chapel Hill,
NC); Ras(15A), RhoA(19N), Rac1(17N), and Cdc42(17N) (Channing
Der, University of North Carolina, Chapel Hill, NC); Src(K295M) (Sara
Courtneidge, Sugen); PI3-kinase Dp85 (A. Baldwin and M. Mayo, Uni-
versity of North Carolina, Chapel Hill, NC); dynamin(K44A) (Marc
Caron, Duke University, Durham, NC); c-Raf-1(621A and R89L) and
B-Raf (621A and R89L) (D. Morrison, National Cancer Institute, Fred-
erick, MD); and HA-tagged ERK2 (Melanie Cobb, University of Texas
Southwestern Medical School, Dallas, TX). Other plasmids used encoded
enhanced cyan fluorescence protein (Invitrogen, San Diego, CA) and
glutathione S-transferase (GST) plasmids encoding the c-Jun (1–79)–
GST fusion protein (Shelton Earp, University of North Carolina, Chapel
Hill, NC) and the Rac-binding domain (RBD)–GST fusion protein
(Richard Cerione, Cornell University, Ithaca, NY).
Cell cultures and methods of L1 clustering. To produce a cell line stably
expressing human L1 (with RSLE), we transfected rat B35 neuroblas-
toma cells (Schubert et al., 1974) with human neuronal L1 cDNA in the
pcDNA3 vector (gift of John Hemperly, Becton Dickinson). After selec-
tion in 0.5 mg/ml G418, 17 clones were assayed for L1 expression by
Western blotting, and L1 localization on the cell surface was verified by
indirect immunofluorescence staining with Neuro4 antibodies. One clone
(designated B35-L1) exhibiting intermediate levels of L1 expression was
chosen for the studies reported here. B35-L1 cells were maintained in
DMEM containing 10% fetal bovine serum (FBS; HyClone, Logan, UT)
and G418 (0.25 mg/ml). Primary cultures of mouse cerebellar neurons
were prepared from postnatal day 8 Sv129/C6B57 hybrid mice by the
method of Schnitzer and Schachner (1981) and grown in DMEM with
10% FBS (HyClone), 25 mM KCl, and penicillin /streptomycin. The
medium was replaced with OptiMEM (Life Technologies, Gaithersburg,
MD), and cells were incubated for 8 hr before initiating signaling. For
clustering of L1 on B35-L1 cells and cerebellar neurons, L1 monoclonal
antibody Neuro4 (30 mg) or L1–Fc fusion proteins (50 mg) were prein-
cubated with F(ab9)2 fragments of secondary antibodies raised against Fc
fragments of mouse or human IgG for 1 hr at 4°C in 50 ml of OptiMEM.
The complexes were added directly to cells in a 60 mm dish containing
1 ml of medium at 37°C. Clustering of L1 into patches on the cell surface
was observed by indirect immunofluorescence staining (data not shown).
MAPK phosphorylation assays. Cells were stimulated with the indi-
cated L1 antibodies or fusion proteins, rinsed once with cold HBSS, and
extracted in Nonidet P-40 (NP-40) lysis buffer containing 1% NP-40,
0.25% (w/v) Na-deoxycholate, 50 mM HEPES, pH 7.4, 137 mM NaCl, 1
mM Na-EDTA, 10 mM NaF, 1 mM Na-orthovanadate, 10 mM
p-nitrophenylphosphate, 1 mM phenylmethylsulfonyl fluoride, 10 mM
b-glycerophosphate, 10 mg/ml leupeptin, 0.1 TIU/ml aprotinin, 1 mg/ml
pepstatin, 2 nM calyculin A, and 10% (v/v) glycerol. Lysates were clarified
by centrifugation at 14,000 3 g for 20 min at 4°C. Protein concentration
was determined using the bicinchoninic acid assay (Pierce, Rockford,
IL). Proteins in cell extracts were separated by SDS-PAGE and trans-
ferred to a nitrocellulose membrane. The membrane was blocked for 2 hr
in 1% bovine serum albumin (BSA) in Tris-buffered saline containing
0.05% Tween 20 (TTBS) and then incubated overnight at 4°C either with
anti-active MAPK antibodies or p38 MAPK antibodies in 1% BSA in
TTBS. After washing in TTBS, the membrane was incubated with goat
anti-rabbit IgG horseradish peroxidase conjugate in TTBS for 1 hr. The
membrane was again washed in TTBS, and immune complexes were
detected using enhanced chemiluminescence (ECL; NEN) with Sterling
x-ray film (BioWorld). Membranes were stripped and reprobed in the
same manner with ERK antibodies to detect total ERK protein.
For assaying phosphorylation of HA-tagged ERK2, B35-L1 cells were
transfected for transient expression with an HA-tagged ERK2 plasmid
with or without plasmids expressing dominant-negative mutants. Subcon-
fluent cultures were transfected in 60 mm dishes containing OptiMEM
using Lipofectamine according to the manufacturer’s instructions (Life
Technologies). Signaling experiments were initiated 36–40 hr after
transfection. Cells were lysed in NP-40 lysis buffer, and HA-tagged
ERK2 was immunoprecipitated from cell extracts (500 mg) with anti-HA
antibody (Babco) for 1.5 hr, followed by Protein G-Sepharose for 0.5 hr
at 4°C. Immune complexes were washed in lysis buffer and subjected to
SDS-PAGE, followed by immunoblotting with anti-active MAPK anti-
body. For all assays, the exposed bands on x-ray film were quantitated by
densitometric scanning and analysis with Image-Quant NT software.
MEK inhibitors [2-(29-amino-39-methoxyphenyl)-oxanaphthalen-4-one
(PD98059; 50 mM; New England Biolabs) and 1,4-diamino-2,3-dicyano-
1,4-bis(2-aminophenylthio)butadiene (U0126; 10 mM; Promega)] or a
PI3-kinase inhibitor [Ly294002 (10–20 mg; Promega)] dissolved in di-
methylsulfoxide (DMSO; ,0.01%) was added to cells for 1 hr before
signal initiation. The Rho inhibitor C3 botulinum endotoxin (20 mg) was
added with Lipofectamine (5 mg) to cells for 4 hr before stimulation.
Control cultures received the same concentration of DMSO or
Lipofectamine.
For assaying the activity of c-Jun N-terminal kinase (JNK), cell
extracts (100 mg of protein) in NP-40 lysis buffer were incubated with
c-Jun (1–79)–GST fusion protein for 4 hr at 4°C. Immune complexes
were washed twice with lysis buffer and twice with kinase buffer (25 mM
HEPES, pH 7.4, 25 mM MgCl2, 25 mM b-glycerophosphate, 2 mM
dithiothreitol, 0.1 mM Na-orthovanadate, and 2 mM p-nitrophenyl-
phosphate) and then incubated in kinase buffer with 50 mM ATP and 0.5
mCi of [g 32P]ATP (ICN) at 30°C for 30 min. Proteins were separated on
SDS-PAGE. The dried gel was exposed to x-ray film, and exposed bands
were quantitated by densitometric scanning and analysis with Image-
Quant NT software.
Assay of phosphoinositides. PI3-kinase activity was assayed by immu-
noprecipitating phosphotyrosine-modified PI3-kinase from cell extracts
with phosphotyrosine antibodies and measuring the production of phos-
phoinositides from phosphatidylinositol in an immune complex kinase
assay (Myers et al., 1993). Cell extracts (800 mg) were incubated with
phosphotyrosine antibody 4G10 for 8 hr at 4°C and then for 1 hr with
Protein G-Sepharose. Immunoprecipitates were collected and washed
twice with buffers I, II, and III (buffer I, 20 mM Tris, pH 7.4, 150 mM
NaCl, 1% NP-40, and 100 mM Na-orthovanadate; buffer II, 100 mM Tris,
pH 7.4, 500 mM LiCl, and 100 mM Na-orthovanadate; and buffer III, 10
mM Tris, pH 7.4, 100 mM NaCl, and 100 mM Na-orthovanadate). Phos-
phatidylinositol (0.5 mg/ml; Avanti Polarlipids) was sonicated in 20 mM
Tris, pH 7.4, and 1 mM Na-EGTA and incubated with the immune
complexes for 10 min at room temperature in kinase reaction buffer
(total volume of 50 ml) containing 20 mM ATP, 1 mCi of [g 32P]ATP (3000
Ci/mmol), 10 mM MgCl2, 20 mM Tris, pH 7.4, and 100 mM NaCl. The
reaction was terminating by adding 6N HCl (15 ml) and 1:1 (v/v) chlo-
roform:methanol (120 ml). Samples were vortexed for 30 sec and centri-
fuged at 10,000 3 g for 1 min. Aliquots (30 ml) of the chloroform phase
were spotted on SilicaG60 plates (Whatman, Maidstone, UK) and sub-
jected to thin-layer chromatography in chloroform:methanol:25% (w/w)
NH4OH:water (60:47:2:11.3, v/v/v/v). Commercially available phospha-
tidylinositol 4-phosphate (PIP; Sigma, St. Louis, MO) was used to
indicate the location of the product. The plate was dried and exposed to
4178 J. Neurosci., June 1, 2000, 20(11):4177–4188 Schmid et al. • L1/MAPK Mediates Neurite Growth by Src-Regulated Endocytosis
x-ray film. Phospholipids were visualized by incubating the thin-layer
plate with iodine vapors, and radioactive spots were scraped from the
plate and quantitated for 32P incorporation in a scintillation counter.
Assays for GTP-bound p21 rac and Raf kinase activity. For measure-
ment of activated, GTP-bound Rac (Bagrodia et al., 1998), B35-L1 cells
were stimulated with L1 antibodies or normal IgG as described; then
lysates (500 mg) were incubated for 30 min at 4°C with 20 mg of a purified
GST fusion protein (RBD–GST) consisting of the Rac-binding domain
of PAK1 together with glutathione Sepharose. RBD–GST binds only to
the activated form of Rac (Rac–GTP) but not to inactive Rac–GDP.
RBD–GST/Rac–GTP complexes were collected by centrifugation and
analyzed by SDS-PAGE and Western blotting with anti-Rac antibodies
(Transduction Laboratories, Lexington, KY).
To assay Raf activation, we subjected lysates in NP-40 lysis buffer (800
mg) to immunoprecipitation using polyclonal antibodies specific for c-Raf
or B-Raf (Santa Cruz Biotechnology) and Protein G-Sepharose. In a
coupled assay measuring myelin basic protein (MBP) phosphorylation
(Upstate Biotechnology, Lake Placid, NY), Raf immune complexes were
preincubated with inactive MEK and MAPK for 30 min at 37°C and then
with MBP and [g 32P]ATP for 10 min at 37°C. MBP was adsorbed to
Whatman P81 paper and quantitated for incorporation of radioactivity by
scintillation counting. An activated form of Raf provided by the manu-
facturer was used as a positive control. The amounts of Raf immunopre-
cipitated were determined in parallel by immunoblotting with Raf
antibodies.
Measurement of neurite outgrowth. Cultures of mouse cerebellar neu-
rons consisting chiefly of granule cells were prepared from postnatal day
7 or 8 pups by the method of Schnitzer and Schachner (1981).
Immunoaffinity-purified L1 protein from adult mice brain was applied in
10 ml spots onto nitrocellulose-coated plastic coverslips (22 3 22 mm 2) in
35 mm Petri dishes as described (Ignelzi et al., 1994). After blocking with
1% bovine serum albumin, 2 3 10 6 cerebellar cells were added per
coverslip in 2 ml of basal medium with Eagle’s salts (Life Technologies)
with 10% heat-inactivated horse serum, 2.5 gm/l glucose, and penicillin /
streptomycin. No neurons attached to uncoated areas of the nitrocellu-
lose. The MEK inhibitors PD98059 and U0126 were dissolved in DMSO
and added at the time of plating at 50 or 10 mM final concentration,
respectively, resulting in a final concentration of 0.1% DMSO. Control
cultures received the same concentration of DMSO. Cells were fixed
after 24 hr with 4% p-formaldehyde and then mounted on microscope
slides. The length of the longest neurite per cell was measured using a
microscope-mounted image processor with cursor overlay. Only neurites
longer than ;10 mm and not in contact with other cells were measured.
Neuron attachment to L1 was assayed by counting at least 100 cells from
30 or more randomly selected fields. Data were obtained from three
independent experiments.
Immunofluorescence staining for endocytosis of L1. For experiments in
which cell surface L1 and endocytosed L1 were differentially labeled in
living cells, a modification of the method of Kamiguchi et al. (1998) was
used. Rat B35-L1 neuroblastoma cells (20,000 cells/well) were plated in
LabTek II chamber slides (Nunc, Naperville, IL) coated with poly-D-
lysine. After 24 hr, cells were transfected using Lipofectamine with a
plasmid encoding enhanced cyan fluorescence protein (0.15 mg of cDNA)
together with a plasmid expressing one of the following (0.25 mg of
cDNA): wild-type c-Src, kinase-inactive Src(K295M), dominant-negative
dynamin(K44A), or dominant-negative PI3-kinase (Dp85). At 24 hr after
the start of transfection, cells were incubated for 45 min at 37°C with 25
mg/ml Neuro4 IgG or normal mouse IgG to induce endocytosis. Cells
were washed with cold DMEM and then incubated with goat anti-mouse
IgG conjugated to rhodamine for 30 min at 4°C to label L1 on the cell
surface. The cells were rinsed with HBSS and fixed in 4%
p-formaldehyde for 30 min. After washing cells once with 0.1 mM glycine
in PBS and twice with PBS, cells were blocked with goat anti-mouse IgG
for 1 hr at 4°C. After rinsing once in cold PBS, the cells were again fixed
in 4% p-formaldehyde for 10 min at room temperature. Cells were
washed once with 0.1 mM glycine in PBS and twice with PBS, and the
membrane was permeabilized with 0.1% Triton X-100 in PBS containing
10% goat serum for 1 hr at room temperature. Cells were washed once
with PBS and incubated with anti-mouse IgG conjugated to fluorescein
isothiocyanate (FITC) for 1 hr to label cytoplasmic L1. After additional
washes, slides were mounted with Vectashield. Cells were viewed in a
Zeiss LSM10 confocal laser microscope equipped with an argon laser
(excitation lines of 488 and 514 nm) resulting in an optical thickness of
0.5 mm at the University of North Carolina Microscopy Services Facility,
Department of Pathology (Chapel Hill, NC; Dr. Bob Bagnell, Director).
RESULTS
L1 clustering activates the MAPK pathway in
cerebellar neurons
L1 signal transduction was investigated in primary cultures of
mouse cerebellar neurons, which express endogenous L1 and are
comprised of .90% granule cells (Schnitzer and Schachner,
1981). Signaling by cell adhesion molecules of the Ig superfamily,
such as neural cell adhesion molecule (NCAM), integrins, and
certain receptor tyrosine kinases, is initiated by the clustering of
receptors with multivalent ligands or antibodies (Heldin, 1995).
L1 molecules were clustered on the surface of cerebellar neurons
with antibodies against the L1 extracellular domain; then cell
lysates were analyzed by immunoblotting with phospho-specific
MAPK antibodies recognizing a dually phosphorylated/activated
form of the extracellular-regulated kinases ERK1 and ERK2.
These MAP kinases are activated by dual phosphorylation of Thr
202 and Tyr 204 (Crews et al., 1992; Marshall, 1994). L1 cluster-
ing in cerebellar neurons stimulated ERK2 dual phosphorylation
fivefold, increasing rapidly within 5–10 min and then declining to
nearly basal levels by 20 min (Fig. 1). The decline in phosphory-
Figure 1. Clustering of L1 in cerebellar neurons activates ERK2. A, Top,
Cerebellar cultures were incubated with nonimmune mouse IgG (NIgG),
monoclonal antibodies against L1 (Neuro4) complexed with F(ab9)2 frag-
ments of anti-mouse IgG (L1 Ab), or L1–Fc fusion protein complexed
with F(ab9)2 fragments of anti-human IgG (L1 protein). Where indicated
(1PD), cells were treated with the MEK inhibitor PD98059 (PD; 25 mM).
Cell extracts were subjected to SDS-PAGE and immunoblotting with
anti-active MAPK antibodies specific for phosphorylated ERKs ( pERK1
and pERK2). Bottom, The same nitrocellulose filter was stripped and
reblotted with antibodies recognizing phosphorylated and nonphospho-
rylated ERK proteins (ERK1 and ERK2). This experiment was repeated
twice with similar results. B, Densitometric quantification of the ERK
phosphorylation in A is shown in arbitrary units of phosphorylation
relative to that of the nonimmune IgG control. Error bars indicate SEs
based on three experiments; an asterisk denotes statistical significance
( p , 0.05).
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lation could be caused by activation of a dual specificity tyrosine/
threonine phosphatase such as MAPK phosphatase (MKP-1)
(Fuller et al., 1997) or L1-triggered phosphatase activities present
in a subcellular fraction enriched in growth cone membranes
(Klinz et al., 1995). L1 clustering did not induce phosphorylation
of ERK1 in the cerebellar neuron cultures even though similar
levels of ERK1 and ERK2 were indicated by immunoblotting with
antibodies against ERK1 and ERK2 protein (Fig. 1A). Nonim-
mune IgG complexes had no effect on ERK phosphorylation.
Multivalent L1 protein, consisting of the L1 extracellular region
fused to the Fc portion of human IgG, also stimulated the
phosphorylation of ERK2 approximately four- to fivefold in cer-
ebellar neurons with kinetics similar to that induced by L1 anti-
body complexes (Fig. 1). ERK2 phosphorylation in cerebellar
neurons induced by cross-linked L1 antibodies or L1–Fc protein
was effectively inhibited by the inhibitor PD98059, which is spe-
cific for MEK (MAP kinase kinase) (Fig. 1). PD98059 binds the
inactive form of MEK1 and to a lesser extent MEK2, preventing
the MEK activation required for MAPK phosphorylation (Alessi
et al., 1995).
An intact MAPK pathway is required for neurite
outgrowth on L1
To determine whether the MAPK pathway participated in L1-
directed neurite outgrowth, primary cultures of mouse cerebellar
neurons (postnatal day 7–8) were analyzed for neurite outgrowth
on purified mouse L1 protein adsorbed to nitrocellulose-coated
dishes as described previously (Ignelzi et al., 1994). L1-stimulated
neurite outgrowth was inhibited by the MEK inhibitors PD98059
and U0126 (Fig. 2, Table 1). Mean neurite length decreased 56%
in the presence of PD98059 and 66% with U0126 (Fig. 2). U0126
was slightly more effective than PD98059, probably because
U0126 inhibits active and inactive forms of MEK (Favata et al.,
1998). The residual neurite outgrowth observed in the presence
of MEK inhibitors suggested that there may be both MAPK-
dependent and -independent pathways for neurite growth on L1.
Neither PD98059 nor U0126 affected cerebellar neuron attach-
ment to purified L1 protein (Table 1; Cells/mm2), the ability of
cerebellar neurons to initiate neurite growth (Table 1; Cells with
neurites/mm2; % cells with neurites), or the morphology of the
neurons. Cells did not adhere to or extend neurites on areas of
the nitrocellulose-coated dishes without L1 protein. Effects on
fasciculation could not be evaluated in these sparsely plated
cultures. These results reveal a functional role for the MEK–
MAPK pathway in L1-dependent neurite outgrowth by cerebellar
neurons.
L1 activates ERK1 and ERK2 in B35-L1
neuroblastoma cells
The rat neuroblastoma cell line B35 (Schubert et al., 1974) is a
useful CNS model for investigating signaling pathways of neural
cell adhesion molecules (Schmid et al., 1999). The B35 cell line
displays differentiated neuronal properties such as membrane
excitability and expression of enzymes for neurotransmitter me-
tabolism (Schubert et al., 1974) and is more easily transfected
than primary neurons. B35 cells express little or no L1 as detected
by immunoblotting and immunofluorescence staining with L1
antibodies. To define the L1-signaling pathway for MAPK acti-
vation further, a B35 cell line was generated that stably expressed
the RSLE-containing neuronal isoform of L1 (B35-L1 cells).
L1 molecules were clustered on the surface of B35-L1 cells with
L1 antibody complexes; then cell lysates were analyzed for dual
phosphorylation of endogenous MAPKs by immunoblotting with
phospho-specific MAPK antibodies. Phosphorylation of both
ERK1 and ERK2 increased four- to fivefold within 10 min of L1
clustering, whereas nonimmune IgG had no effect (Fig. 3A,B).
Phosphorylation was rapid and transient with similar kinetics for
ERK1 and ERK2. Clustering of L1 on the cell surface was
necessary for MAPK activation, because monovalent Fab frag-
ments of L1 antibodies did not induce ERK phosphorylation
(data not shown). The ability of L1 to stimulate phosphorylation
of ERK1 and ERK2 in B35-L1 cells, in contrast to the phosphor-
ylation of only ERK1 in cerebellar neurons, suggested that these
pathways were differentially regulated. Similar results were ob-
tained during NCAM stimulation in cerebellar neurons and B35
cells expressing NCAM140 (Schmid et al., 1999). Selective acti-
vation of ERK2 and not ERK1 in neuronal cells also occurs
during stimulation of protein kinase C or NMDA receptors
(English and Sweatt, 1996). Differential MAPK regulation was
characterized previously in yeast in which mating and pseudohy-
phal differentiation are independently controlled by the MAPKs
Fus3 and Kss1 (Madhani et al., 1997).
To address the specificity of L1 activation of the MAPK-
signaling pathway, B35-L1 cells were assayed for L1-dependent
phosphorylation of the MAP kinases, JNK, and p38, which are
activated in response to multiple cellular stressors (Waskiewicz
and Cooper, 1995). No increase of JNK phosphorylation was
observed within 5–20 min of L1 clustering, whereas sorbitol-
treated cells as a positive control showed prominent JNK activity
(Fig. 3C). Similarly, the phosphorylation of p38 MAPK was not
increased over basal levels compared with anisomycin-treated
cells as positive controls (Fig. 3D).
L1 activates the MAPK pathway via PI3-kinase
and Rac
To investigate whether L1 clustering activated PI3-kinase in L1
antibody-triggered B35-L1 cells, the production of phosphoi-
nositides by PI3-kinase was quantitatively determined. During
activation, PI3-kinase becomes phosphorylated on tyrosine and
can be immunoprecipitated with phosphotyrosine antibodies. In-
cubation of immune complexes from L1 antibody-stimulated
B35-L1 cells with phosphatidylinositol and [g32P]ATP produced
radiolabeled phosphatidylinositol 3-phosphate, which was sepa-
Figure 2. Effect of MEK inhibitors on L1-dependent neurite outgrowth
by cerebellar neurons. Mouse cerebellar neurons were plated on purified
L1 protein adsorbed to nitrocellulose-coated coverslips and allowed to
extend neurites for 24 hr without or with MEK inhibitors (50 mM
PD98059 or 10 mM U0126). Cells were fixed, neurite lengths were mea-
sured, and results were plotted in a neurite length distribution curve. Two
hundred or more cells were analyzed for each condition (see Table 1 for
additional data). This experiment was repeated twice with similar results.
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rated from reactants by thin-layer chromatography (Fig. 4A). The
amount of activated PI3-kinase increased two- to threefold within
3–8 min after antibody triggering. A similar extent of increase in
PI3-kinase activity occurs in cells treated with epidermal growth
factor (EGF), platelet-derived growth factor, or phorbol esters
and is effective in mediating their physiological functions (Con-
ricode, 1995; Nave et al., 1996; Cross et al., 1997). To determine
whether PI3-kinase was involved in regulating L1-triggered ERK
phosphorylation, a dominant-negative PI3-kinase mutant (Dp85)
was cotransfected with HA–ERK2 for transient expression in
B35-L1 cells. This dominant inhibitory mutant contains a deletion
in the PI3-kinase regulatory subunit (p85) that abolishes its
binding to the catalytic subunit (p110) (Hara et al., 1994). Stim-
ulation of B35-L1 cells expressing this mutant with L1 antibodies
resulted in complete inhibition of ERK2 phosphorylation (Fig.
4B). Treatment of B35-L1 cells with 10 mM Ly294002, a selective
chemical inhibitor of PI3-kinase (Vlahos et al., 1994), prevented
L1 antibody-induced phosphorylation of endogenous ERK1 and
ERK2 (Fig. 4D).
Rac and Cdc42 are members of the Rho family of small
GTPases that regulate actin cytoskeletal dynamics (Ridley et al.,
1992), signal to JNK (Vojtek and Cooper, 1995), and cause
cross-cascade activation of the ERK pathway (Frost et al., 1997).
PI3-kinase contributes to the activation of Rac and Cdc42 by
providing phosphoinositides that bind the plextrin homology do-
main of specific guanine nucleotide exchange factors (GEFs)
(Quilliam et al., 1995). To investigate the role of small GTPases
in L1-stimulated MAPK activation, B35-L1 cells were cotrans-
fected with HA-tagged ERK2 and dominant-negative Rac1,
Ccd42, and RhoA plasmids, which act by sequestering respective
GEFs. ERK2 phosphorylation in antibody-triggered B35-L1 cells
was effectively blocked by the expression of dominant-negative
Rac1(17N) but not RhoA(19N) or Cdc42(17N) mutants (Fig.
4B). C3 botulinum toxin, which inhibits RhoA, B, and C but not
Rac or Cdc42 (Braun et al., 1989; Chrzanowska-Wodnicka and
Burridge, 1996), also had no effect on L1-dependent ERK phos-
phorylation (Fig. 4D). The participation of Rac in L1 signaling
was confirmed in an assay that directly measured the production
of activated, GDP-bound Rac (Bagrodia et al., 1998). Cell lysates
from L1 antibody-treated B35-L1 cells were incubated with puri-
fied RBD–GST fusion protein, which selectively binds Rac–GTP
and not Rac–GDP. The amount of Rac–GTP pulled down by the
RBD–GST complexes was significantly increased after L1 stim-
ulation of B35-L1 cells (Fig. 4C). These results supported a role
for Rac in L1 signaling to MAPK.
L1-triggered MAPK activation in B35-L1 neuroblastoma cells
differed from NCAM140 signaling to MAPK in its independence
from Ras and the focal adhesion kinase p125fak. Cotransfection of
B35-L1 cells with HA–ERK2 and a dominant-negative Ras(15A)
plasmid, which sequesters Ras–GEFs (Quilliam et al., 1994), had
no effect on L1 antibody-stimulated ERK phosphorylation,
whereas it strongly inhibited MAPK activation by EGF (Fig. 4B).
Expression of a Ras dominant-negative mutant (Ras17N) or a
competitive N-terminal Raf peptide that binds Ras (Brtva et al.,
1995) also had no effect (data not shown). Under the same
conditions, Ras(15A) and Ras(17N) interfered strongly with
NCAM140-dependent MAPK activation in B35 cells (Schmid et
al., 1999). In a coupled immune complex kinase assay for Raf-
induced phosphorylation of MBP (Fucini et al., 1999), neither
c-Raf nor B-Raf became activated to a significant degree (.10%
over the normal IgG control) during L1 antibody stimulation of
B35-L1 cells. Dominant-negative Raf-1 or B-Raf mutants (S621A
or R89L) also produced insignificant inhibition of ERK2 phos-
phorylation (.1.2-fold).
Similarly, expression of FRNK (Schaller et al., 1993; Richard-
son and Parsons, 1996) or the autophosphorylation site mutant
Fak(Y397F) (Schaller et al., 1994), which are dominant interfer-
ing inhibitors of p125fak, did not affect L1-triggered HA–ERK2
activation (Fig. 4B), whereas under the same conditions they
inhibited NCAM140-triggered MAPK activation in B35 cells
(Schmid et al., 1999). Tyrosine phosphorylation of p125fak was
also not increased after L1 antibody triggering, as assessed by
Western blotting with phosphotyrosine antibodies in Fak immu-
noprecipitates (data not shown).
pp60c-src mediates ERK phosphorylation induced by L1
Because neuronal process extension on purified L1 is regulated
by the nonreceptor tyrosine kinase pp60c-src (Ignelzi et al., 1994),
we investigated whether pp60c-src played a role in MAPK activa-
tion triggered by L1. B35-L1 neuroblastoma cells were cotrans-
fected with HA–ERK2 and the dominant-negative c-Src(K295M)
plasmid, which expresses a kinase-inactive form of pp60c-src be-
cause of mutation of an essential lysine residue (K295) in the ATP
binding site (Twamley-Stein et al., 1993). Expression of the
dominant-negative src plasmid inhibited ERK2 phosphorylation
by ;70% in B35-L1 neuroblastoma cells treated with L1 antibod-
ies (Fig. 5A). Moreover, endogenous ERK2 phosphorylation in
cerebellar neurons from src-minus mice was 60% lower than that
in wild-type neurons (Fig. 5B). The residual ERK2 phosphoryla-
tion in src-minus neurons and B35-L1 cells expressing dominant-
negative Src suggested that there may an additional L1 pathway
that is pp60c-src independent, in accord with the incomplete
inhibition of L1-dependent neurite outgrowth in MEK-inhibited
cells and by src-minus neurons (Ignelzi et al., 1994). L1 did not
form a stable complex with pp60c-src, because L1 and pp60c-src did
not coimmunoprecipitate from Brij97-detergent extracts of
B35-L1 cells with or without L1 clustering (data not shown) under
the same conditions in which NCAM140 coimmunoprecipitated
with the Src family kinase p59fyn (Beggs et al., 1997).
Table 1. Inhibition of neurite outgrowth on L1 by MEK inhibitors
Mean neurite length





Untreated 152 6 12* 253 38 34 90
PD98059 (50 mM) 67 6 4* 264 36 33 91
U0126 (10 mM) 52 6 1* 200 35 32 90
n represents the number of cells measured for mean neurite length. Mean neurite lengths were obtained in three
independent experiments. More than 200 cells were scored for neurite length in each condition.
*Statistically significant differences in means of treated and untreated samples using a t test ( p , 0.05).
Schmid et al. • L1/MAPK Mediates Neurite Growth by Src-Regulated Endocytosis J. Neurosci., June 1, 2000, 20(11):4177–4188 4181
pp60c-src is required for dynamin-mediated
endocytosis of L1
L1 has been shown to be endocytosed at the growth cone by a
clathrin-mediated mechanism (Kamiguchi et al., 1998). To deter-
mine whether L1 endocytosis was mediated by pp60c-src, B35-L1
cells were analyzed for L1 endocytosis by double immunofluo-
rescence staining to visualize internalized and surface L1 with
different fluorochromes. Cells were transfected with plasmids
encoding wild-type Src, kinase-inactive Src(K295M), or
dominant-negative dynamin(K44A) together with a plasmid ex-
pressing cyan fluorescent protein to identify transfected cells. To
induce internalization of L1, we incubated living cells for 30 min
at 37°C with the monoclonal antibody Neuro4, which is directed
against an extracellular epitope of L1. Cells were fixed and
stained for L1 on the cell surface with rhodamine-conjugated
secondary antibodies. Cells were then permeabilized and stained
for internalized L1 with FITC-conjugated secondary antibodies.
Confocal microscopy revealed strong FITC labeling of internal-
ized L1 antibody complexes in a punctuate, vesicular pattern
throughout the cytosol both in cyan-positive cells (Fig. 6, arrows,
arrowheads) expressing wild-type Src from a transfected plasmid
(Fig. 6A,E) and in nontransfected cells expressing endogenous
Src (Fig. 6D,H). This observation suggested that the amount of
endogenous pp60c-src was not rate-limiting for endocytosis of L1
antibody complexes in B35-L1 cells. In striking contrast, cyan-
positive cells (Fig. 6, arrows, arrowheads) in cultures transfected
with dominant-negative Src(K95M) showed little L1 endocytosis
(Fig. 6B,F,C,G), whereas cyan-negative cells serving as nontrans-
fected controls within the same cultures exhibited prominent
vesicular staining in the cytosol. Rhodamine staining for L1 on
the cell surface appeared relatively unaltered by endocytosis,
suggesting that the amount of internalized L1 was a relatively
small portion of the total L1 expressed in B35-L1 cells. L1
endocytosis was not inhibited in B35-L1 cells treated with the
MEK inhibitor PD98059 (50 mM) (Fig. 6J,N), in cells expressing
PI3-kinase Dp85 (Fig. 6K,O), or in cells treated with the PI3-
kinase inhibitor Ly294002 (20 mM), suggesting that PI3-kinase
and MEK-MAPK did not contribute to the mechanism of
endocytosis.
Dynamin GTPase plays a critical role in the formation of
clathrin-coated vesicles during endocytosis of many receptors
(Hinshaw and Schmid, 1995), as shown by the ability of dominant-
negative dynamin(K44A) to block effectively the formation of
endocytotic-coated vesicles (Damke et al., 1994). Dynamin-
(K44A) also prevented L1 internalization in L1-B35 cells (Fig.
6M), confirming its role in internalizing L1 by a clathrin-
mediated mechanism (Kamiguchi et al., 1998) in B35 cells. Al-
though Rac has been shown to modulate receptor-mediated en-
docytosis in some systems (Lamaze et al., 1996), expression of
dominant-negative Rac1(17N) in B35 cells did not affect L1
antibody-induced internalization (data not shown), suggesting
that this small GTPase did not regulate L1 endocytosis. Impor-
tantly, the dynamin(K44A) mutant effectively inhibited L1
antibody-induced phosphorylation of HA–ERK2 in transfected
B35-L1 cells (Fig. 5A), thus indicating that an intact endocytotic
mechanism was necessary for L1 triggering of the MAPK
cascade.
Taken together these results demonstrated that the dynamin-
mediated internalization of L1 in B35-L1 cells depended on
pp60c-src and that L1 endocytosis was required for activation of an
MAPK cascade that regulated neurite outgrowth on L1.
DISCUSSION
Here we report that an MAPK-signaling pathway mediates neu-
rite outgrowth on L1 and requires pp60c-src-dependent endocyto-
sis. This is the first demonstration of a neuronal function regu-
lated by L1 via MAPK and of the role of pp60c-src in regulating
Figure 3. Clustering of L1 in B35 neuroblastoma cells transiently acti-
vates MAPK but not JNK or p38. A, Top, Rat B35 neuroblastoma cells
stably expressing L1 (B35-L1) were incubated with either nonimmune
mouse IgG or L1 mAb Neuro4 complexed with F(ab9)2 fragments of
anti-mouse IgG for various times (5–20 min). Cell extracts were subjected
to SDS-PAGE and immunoblotting with anti-active MAPK antibodies
( pERK1 and pERK2). Bottom, The same nitrocellulose filter was stripped
and reblotted with an ERK antibody recognizing ERK1 and ERK2. This
experiment was repeated three times with similar kinetics and extent of
MAPK activation. B, Densitometric quantification of MAPK phosphor-
ylation in the experiment shown in A is expressed in arbitrary units of
ERK1 and ERK2 phosphorylation relative to that of the nonimmune IgG
control. Error bars indicate SEs based on three experiments; an asterisk
denotes statistical significance ( p , 0.05). C, The same cell extracts
shown in A were assayed for JNK activation by the JNK immune complex
kinase assay. Autoradiography showed no increase in the phosphorylation
of c-Jun(1–79) by JNK from L1-stimulated cells ( p c-Jun). As a positive
control, cells were incubated with 300 mM sorbitol for 15 min. This
experiment was performed three times with similar results. D, The same
cell extracts shown in A were subjected to SDS-PAGE and immunoblot-
ting with anti-phospho p38 MAPK antibodies, which recognize phosphor-
ylated/activated p38 ( p p38). No increase in phosphorylation levels was
seen. As a positive control, cells were incubated with 10 mM anisomycin
for 10 min. This experiment was performed twice with similar results.
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Figure 4. Dominant-negative mutants of PI3-kinase and Rac1 inhibit MAPK activation induced by L1 clustering in B35 neuroblastoma cells. A, B35-L1
cells were incubated with mouse IgG or the L1 monoclonal antibody Neuro4 complexed with F(ab9)2 fragments of anti-mouse IgG. Cell lysates (800 mg)
were immunoprecipitated with anti-phosphotyrosine mAb (4G10), and the precipitates were incubated in an in vitro kinase reaction with phosphoi-
nositides. Phospholipid products were separated by thin-layer chromatography (top). Error bars in the graph (bottom) indicate SEs based on three
experiments; an asterisk denotes statistical significance ( p , 0.05). B, Top row, B35-L1 cells transiently expressing HA–ERK2 and the dominant-negative
(DN ) mutants PI3-kinase (PI3K ) Dp85, RhoA(19N), Rac1(17N), Cdc42(17N), FRNK, Fak(397F), or Ras(15A) were incubated with mouse IgG or the
L1 monoclonal antibody Neuro4 complexed with F(ab9)2 fragments of anti-mouse IgG. As a control, cells were exposed to 100 ng/ml EGF for 5 min.
Cell extracts were immunoprecipitated with anti-HA antibodies and then subjected to SDS-PAGE and immunoblotting with anti-active MAPK antibody
( p ERK2). Bottom row, The same nitrocellulose filters were stripped and reblotted with an antibody recognizing ERK2 protein. The experiments were
performed three times with similar results. C, B35-L1 cells were incubated with normal mouse IgG or the L1 monoclonal antibody Neuro4 complexed
with F(ab9)2 fragments of anti-mouse IgG for 3 and 8 min. GTP-loaded Rac was pulled down from the cell lysates (500 mg) by the addition of RBD–GST
fusion protein conjugated to Sepharose beads, and the relative levels of Rac–GTP were evaluated by SDS-PAGE and immunoblotting with anti-Rac1
antibodies. D, Top, B35-L1 cells were exposed to the C3 toxin Rho inhibitor or the Ly294002 PI3-kinase inhibitor as described in Materials and Methods
and then incubated with normal mouse IgG or the L1 monoclonal antibody Neuro4 complexed with F(ab9)2 fragments of anti-mouse IgG for 7 min. Cell
extracts were subjected to SDS-PAGE and immunoblotting with anti-active MAPK antibody ( p ERK2). Bottom, The same nitrocellulose filters were
stripped and reblotted with an antibody recognizing ERK2 protein. ori, Origin; Rel, relative.
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dynamin-mediated endocytosis of L1 as an essential initial step in
MAPK activation. Key intermediates on the L1–MAPK-
signaling pathway were identified to be the small GTPase Rac and
PI3-kinase. Because ERKs activate gene expression via phos-
phorylation of the transcription factors Elk-1 (Marais et al., 1993)
and CRE-binding protein (Ginty et al., 1994), these results raise
the possibility that neurite outgrowth may rely on signaling events
in the growth cone and nucleus. The proposed signaling pathway
is outlined in Figure 7.
Results of this study demonstrate the requirement of an intact
MEK–ERK pathway in regulating neurite outgrowth by cerebel-
lar neurons on an L1 substrate. ERK phosphorylation is widely
used for neurite outgrowth in response to pleiotropic axon
growth/guidance cues, which include L1m NCAM (Schmid et al.,
1999), the extracellular matrix (Ihara et al., 1997), and neurotro-
phins (Xia et al., 1995; Riccio et al., 1997). L1 signaling to MAPK
may also function in synaptic plasticity as suggested from anti-
body perturbation experiments (Luthi et al., 1994), because
ERKs are phosphorylated in neurons during b-adrenergic and
serotonergic stimulation (Koch et al., 1994; Michael et al., 1998)
and in hippocampal long-term potentiation (LTP) (English and
Sweatt, 1997). The extent of ERK phosphorylation triggered by
L1 (four- to fivefold) approximated that induced by NCAM
(Schmid et al., 1999), NGF (Riccio et al., 1997), integrins (Chen
et al., 1994), and LTP (English and Sweatt, 1997), underscoring
its potential physiological relevance. By transducing signals that
converge within the MAPK pathway, adhesion molecules, growth
factors, and neurotransmitters may coordinately regulate the
growth or branching of axons and dendrites. While our work was
in progress MAPK was shown to be activated in L1-transfected
NIH3T3 cells dependent on endocytosis (Schaefer et al., 1999).
Our studies in neural cells are in accord with this report but go
further by demonstrating a physiological role for MAPK in L1-
dependent neurite outgrowth and by identifying pp60c-src, Rac,
and PI3-kinase as key signaling intermediates in the pathway.
An important finding of our work is the requirement for
pp60c-src in dynamin-dependent endocytosis of L1 and activation
of MAPKs in neural cells. These results provide a mechanistic
understanding of the inhibition of L1-dependent neurite out-
growth observed in src-minus neuronal cultures (Ignelzi et al.,
1994). Our studies suggest (1) that pp60c-src acts as a gatekeeper
of the MAPK cascade by regulating L1 endocytosis and (2) that
endocytosis and MAPK activation are needed for neurite growth
on L1. Dynamin-mediated endocytosis is also an early step in
MAPK activation induced by EGF (Vieira et al., 1996), serotonin
5-HT1A (Della Rocca et al., 1999), insulin-like growth factor I
(Chow et al., 1998), lysophosphatidic acid (Luttrell et al., 1997),
and b2-adrenergic agonists (Daaka et al., 1998). Although only L1
and the b2-adrenergic receptor have been shown to depend on
pp60c-src for endocytosis and MAPK activation (Ahn et al., 1999),
it is conceivable that Src family kinases may participate in endo-
cytosis/signaling by other receptors. It remains to be determined
whether L1 clustering activates pp60c-src by dephosphorylating
Tyr 527 in the Src C-terminal domain (Bjorge et al., 1996)
possibly via tyrosine phosphatase PTP-a (Ponniah et al., 1999). A
role for tyrosine phosphatases in L1 signaling is consistent with
the ability of L1 antibodies to induce dephosphorylation of ty-
rosine in growth cone proteins (Atashi et al., 1992; Klinz et al.,
1995). Because neurite outgrowth by cerebellar neurons on L1
was not totally suppressed by MEK inhibitors or in src-minus
neurons (Ignelzi et al., 1994), there may be an additional Src/
MAPK-independent mechanism for L1-dependent neurite
growth. For example, neurite growth responses in common to L1,
NCAM, and N-cadherin have been shown to occur via the basic
fibroblast growth factor receptor, phospholipase C, and produc-
tion of arachidonic acid (Saffell et al., 1997). It should be noted
that because different cell types (cerebellar neurons and B35
neuroblastoma cells) were used to measure neurite outgrowth
and endocytosis, the results do not formally prove that endocy-
tosis of L1 is required for the regulation of neurite outgrowth.
Other than pp60c-src it is not clear whether components of the
L1–MAPK cascade identified in B35 cells are also deployed for
signal transduction and neurite outgrowth in cerebellar neurons
and other neuronal cell types. Nonetheless, the finding that
pp60c-src was needed for ERK activation in both cell types and
that deletion of the src gene causes inhibition of neurite out-
growth in cerebellar neurons (Ignelzi et al., 1994) supports the
possibility that Src-dependent endocytosis mediates neurite out-
growth on L1.
L1 signaling, as delineated in B35 cells, differed from the
prototypical Ras–MAPK cascade used by NCAM and integrins
(Schlaepfer and Hunter, 1997; Schmid et al., 1999) in its inde-
pendence from Ras and Fak. However, Ras-independent (Howe
and Juliano, 1998) and FAK-independent signaling pathways are
Figure 5. Dominant-negative mutants of pp60c-src and dynamin inhibit
MAPK activation induced by L1 clustering in B35 neuroblastoma cells. A,
Top, B35-L1 cells transiently expressing HA–ERK2 and the dominant-
negative mutants c-Src(K295M) or dynamin (K44A) were incubated for 7
min with mouse IgG or the L1 monoclonal antibody Neuro4 complexed
with F(ab9)2 fragments of anti-mouse IgG. Cell extracts in NP-40 lysis
buffer were immunoprecipitated with anti-HA antibodies and then sub-
jected to SDS-PAGE and immunoblotting with anti-active MAPK anti-
body ( p ERK2). Bottom, The same nitrocellulose filters were stripped and
reblotted with an ERK antibody recognizing ERK2 protein. The exper-
iments were performed twice with similar results. B, Top, Cerebellar
neurons from wild-type mice (wt) or src-minus mice (src2/2) were
incubated with mouse IgG or the L1 monoclonal antibody Neuro4 com-
plexed with F(ab9)2 fragments of anti-mouse IgG. Buffers of the cell
extracts were subjected to SDS-PAGE and immunoblotting with anti-
active MAPK Ab ( p ERK2). Bottom, The same nitrocellulose filters were
stripped and reblotted with an ERK antibody recognizing ERK2. The
experiments were performed twice with similar results.
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used for some forms of integrin signaling (Lin et al., 1997;
Miranti et al., 1998). FAK-independent signaling in platelets
shares with the L1 pathway the involvement of pp60c-src, Rac, and
PI3-kinase (Miranti et al., 1998). Although we have not found
b1-integrins stably associated with L1, a role for specific
b-integrin subtypes in L1–MAPK signaling remains open, be-
cause L1 has been shown to interact functionally with integrins
for neurite outgrowth and cell migration on L1, mediated in part
by an RGD sequence in the sixth Ig domain (Montgomery et al.,
1996; Yip et al., 1998).
Neuronal growth cones display distinctive morphologies on L1,
NCAM, and laminin (Payne et al., 1992; Abosch and Lagenaur,
1993; Burden-Gulley et al., 1995, 1997); yet each substrate can
activate MAPKs, raising the question of how specificity arises.
Activation of different signaling intermediates on the MAPK
pathway may allow neurons to respond to extracellular cues in
distinct ways. In B35 cells, L1 signals to MAPK via pp60c-src,
PI3-kinase, and Rac, whereas NCAM140 signals to MAPK via
Fyn, FAK, Ras, and Rho (Schmid et al., 1999). Nonetheless, the
involvement of Rac in L1 signaling is consistent with the lamel-
lipodial morphology displayed by growth cones of retinal gan-
glion cells on L1 (Payne et al., 1992; Burden-Gulley et al., 1995).
Activated Rho family GTPases differentially modulate actin cy-
toarchitecture (Nobes and Hall, 1995). Rac generates lamellipo-
dia by inducing actin depolymerization via LIM kinase-1 (Arber
et al., 1998; Yang et al., 1998), Rho induces actin stress fibers and
growth cone collapse (Kozma et al., 1997), and Cdc42 elicits
filopodia via LIM kinase-2 (Sumi et al., 1999). PI3-kinase may
Figure 6. Endocytosis of L1 antibody com-
plexes requires pp60c-src and dynamin. En-
docytosis of L1 antibody complexes induced
with Neuro4 monoclonal antibodies against
an extracellular epitope of L1 was visual-
ized in transfected B35-L1 neuroblastoma
cells by double immunofluorescence stain-
ing for L1 on the cell surface (rhodamine)
and internalized L1 (FITC) using confocal
microscopy as described in Materials and
Methods. B35-L1 cells were cotransfected
with one of the pcDNA3 plasmids listed
below together with equimolar amounts of a
plasmid expressing enhanced cyan fluores-
cent protein (ECFP) as a marker for trans-
fected cells. Arrows and arrowheads denote
ECFP-positive cells. Images show represen-
tative cells from all experiments. A, E,
Wild-type c-Src. B, F, C, G, Dominant-
negative Src(K295M). D, H, No transfec-
tion. I, M, Dominant-negative dynamin-
(K44A). J, N, Treatment with MEK
inhibitor PD98059 (50 mM). K, O,
Dominant-negative PI3-kinase (Dp85). L,
P, Treatment with PI3-kinase inhibitor
Ly294002 (20 mM). A—D and I–L show L1
on the cell surface (rhodamine); E–H and
M–P show internalized L1 (FITC). Scale
bar, 10 mm.
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promote Rac activation via the binding of phosphoinositide prod-
ucts to the plextrin homology domain of Rac–GEFs (Han et al.,
1998; Nimnual et al., 1998). PI3-kinase is an important determi-
nant of growth cone guidance, required for the turning of Xeno-
pus growth cones toward a netrin gradient (Hong et al., 1999).
The ability of L1 to phosphorylate ERKs via Rac could occur
by cross-cascade stimulation of MEK. Rac typically activates the
JNK pathway (Crespo et al., 1996) but is an upstream regulator of
p21-activated kinase, which directly phosphorylates MEK and
stimulates ERK phosphorylation in a Ras-independent manner
(Frost et al., 1997). Such cross-talk allows pathways for Rac
activation to cooperate with prototypical Ras–Raf–MEK–
MAPK pathways (Frost et al., 1997). In this way, NCAM or
neurotrophin signaling via Ras may cooperate with L1 signaling
via Rac for MAPK activation and neurite outgrowth. Although
we found no evidence of c-Raf 1 or B-Raf in L1 signaling, basal
levels of a Raf isoform might participate.
The ability of L1 clustering to activate PI3-kinase also supports
a role for L1 in neuronal survival. PI3-kinase promotes neuronal
survival and blocks apoptosis in response to neurotrophins and
insulin-like growth factor I via the serine/threonine kinase Akt
(Ashcroft et al., 1999). Although Akt was not examined in our
studies, a role for L1 in neuronal survival is consistent with a 30%
reduction in the number of hippocampal neurons in L1 knock-out
mice (Demyanenko et al., 1999) and with the ability of L1 to
enhance the survival of dopaminergic neurons (Hulley et al.,
1998) and to prevent apoptotic death of cerebellar and hippocam-
pal neurons in culture (Chen et al., 1999).
Src-mediated endocytosis of L1 has the potential for not only
local actin cytoskeletal rearrangements in the growth cone but
also nuclear transcriptional control. Via Rac and PI3-kinase, L1
could cause actin rearrangements to form lamellipodial exten-
sions needed for neurite elongation. Endocytosis of L1 might also
serve to release the growth cone from attachment to the substra-
tum, facilitating its forward migration. L1 in endocytic vesicles
would be oriented with its C terminal projecting toward the
cytoplasm, enabling downstream signaling molecules in the
growth cone to be recruited and/or activated, a scenario consis-
tent with the observation that activated ERK colocalizes with L1
in endocytosed vesicles of L1-transfected fibroblasts (Schaefer et
al., 1999). L1-signaling complexes might also be transported from
the growth cone to the cell body, as shown for internalized
NGF–Trk receptor complexes in pheochromocytoma 12 cells
(Riccio et al., 1997). There dually phosphorylated ERKs would
be in position to translocate into the nucleus, where they may
induce transcription of the genes needed for neuronal process
extension or cell survival.
REFERENCES
Abosch A, Lagenaur C (1993) Sensitivity of neurite outgrowth to micro-
filament disruption varies with adhesion molecule substrate. J Neuro-
biol 24:344–355.
Ahn S, Maudsley S, Luttrell LM, Lefkowitz RJ, Daaka Y (1999) Src-
mediated tyrosine phosphorylation of dynamin is required for beta2-
adrenergic receptor internalization and mitogen-activated protein ki-
nase signaling. J Biol Chem 274:1185–1188.
Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995) PD
098059 is a specific inhibitor of the activation of mitogen-activated
protein kinase kinase in vitro and in vivo. J Biol Chem
270:27489–27494.
Appel F, Holm J, Conscience J-F, Schachner M (1993) Several extracel-
lular domains of the neural cell adhesion molecule L1 are involved in
neurite outgrowth and cell body adhesion. J Neurosci 13:4764–4775.
Arber S, Barbayannis FA, Hanser H, Schneider C, Stanyon CA, Bernard
O, Caroni P (1998) Regulation of actin dynamics through phosphor-
ylation of cofilin by LIM-kinase. Nature 393:805–809.
Ashcroft M, Stephens RM, Hallberg B, Downward J, Kaplan DR (1999)
The selective and inducible activation of endogenous PI 3-kinase in
PC12 cells results in efficient NGF-mediated survival but defective
neurite outgrowth. Oncogene 18:4586–4597.
Atashi JR, Klinz SG, Ingraham CA, Matten WT, Schachner M, Maness
PF (1992) Neural cell adhesion molecules modulate tyrosine phos-
phorylation of tubulin in nerve growth cone membranes. Neuron
8:1–20.
Bagrodia S, Taylor SJ, Jordon KA, Van Aelst L, Cerione RA (1998) A
novel regulator of p21-activated kinases. J Biol Chem 273:23633–23636.
Beggs HE, Baragona SC, Hemperly JJ, Maness PF (1997) NCAM-140
interacts with the focal adhesion kinase p125 fak and the src-related
tyrosine kinase p59 fyn. J Biol Chem 272:8310–8319.
Bjorge JD, O’Connor TJ, Fujita DJ (1996) Activation of human pp60c-
src. Biochem Cell Biol 74:477–484.
Braun U, Habermann B, Just I, Aktories K, Vandekerckhove J (1989)
Purification of the 22 kDa protein substrate of botulinum ADP-
ribosyltransferase C3 from porcine brain cytosol and its characteriza-
tion as a GTP-binding protein highly homologous to the rho gene
product. FEBS Lett 243:70–76.
Brtva TR, Drugan JK, Ghosh S, Terrell RS, Campbell-Burk S, Bell RM,
Der CJ (1995) Two distinct Raf domains mediate interaction with
Ras. J Biol Chem 270:9809–9812.
Burden-Gulley SM, Payne HR, Lemmon V (1995) Growth cones are
actively influenced by substrate-bound adhesion molecules. J Neurosci
15:4370–4381.
Burden-Gulley SM, Pendergast M, Lemmon V (1997) The role of cell
adhesion molecule L1 in axonal extension, growth cone motility, and
signal transduction. Cell Tissue Res 290:415–422.
Figure 7. Proposed L1-signaling pathway. Cross-linking of L1 molecules
on the growth cone membrane is proposed to induce dynamin-mediated
endocytosis of L1 via the Src tyrosine kinase, leading to initiation of an
intracellular signal transduction cascade involving the sequential activa-
tion of PI3-kinase, Rac, MEK, and MAPK. Inhibitors of PI3-kinase
(Ly294002) and MEK (PD98059 and U0126) are shown. It is suggested
that Rac activation in the growth cone leads to cytoskeletal changes
resulting in lamellipodia and that MAPK may have nuclear effects on
gene expression, both of which may be needed for neurite outgrowth.
4186 J. Neurosci., June 1, 2000, 20(11):4177–4188 Schmid et al. • L1/MAPK Mediates Neurite Growth by Src-Regulated Endocytosis
Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL (1994) Integrin-
mediated cell adhesion activates mitogen-activated protein kinases.
J Biol Chem 269:26602–26605.
Chen S, Mantei N, Dong L, Schachner M (1999) Prevention of neuronal
cell death by neural adhesion molecules L1 and CHL1. J Neurobiol
38:428–439.
Chow JC, Condorelli G, Smith RJ (1998) Insulin-like growth factor-I
receptor internalization regulates signaling via the Shc/mitogen-
activated protein kinase pathway, but not the insulin receptor
substrate-1 pathway. J Biol Chem 273:4672–4680.
Chrzanowska-Wodnicka M, Burridge K (1996) Rho-stimulated contrac-
tility drives the formation of stress fibers and focal adhesions. J Cell
Biol 133:1403–1415.
Cohen NR, Taylor JSH, Scott LB, Guillery RW, Soriano P, Furley AJW
(1997) Errors in corticospinal axon guidance in mice lacking the neural
cell adhesion molecule L1. Curr Biol 8:26–33.
Conricode KM (1995) Involvement of phosphatidylinositol 3-kinase in
stimulation of glucose transport by growth factors in 3T3–L1 adipo-
cytes. Biochem Mol Biol Int 36:835–843.
Crespo P, Bustelo XR, Aaronson DS, Coso OA, Lopez-Barahona M,
Barbacid M, Gutkind JS (1996) Rac-1 dependent stimulation of the
JNK/SAPK signaling pathway by Vav. Oncogene 13:455–460.
Crews CM, Alessandrini A, Erikson RL (1992) The primary structure of
MEK, a protein kinase that phosphorylates the ERK gene product.
Science 258:478–480.
Cross DA, Watt PW, Shaw M, van der Kaay J, Downes CP, Holder JC,
Cohen P (1997) Insulin activates protein kinase B, inhibits glycogen
synthase kinase-3 and activates glycogen synthase by rapamycin-
insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett
406:211–215.
Daaka Y, Luttrell LM, Ahn S, Della Rocca GJ, Ferguson SS, Caron MG,
Lefkowitz RJ (1998) Essential role for G protein-coupled receptor
endocytosis in the activation of mitogen-activated protein kinase. J Biol
Chem 273:685–688.
Dahlin-Huppe K, Berglund EO, Ranscht B, Stallcup WB (1997) Muta-
tional analysis of the L1 neuronal cell adhesion molecule identifies
membrane-proximal amino acids of the cytoplasmic domain that are
required for cytoskeletal anchorage. Mol Cell Neurosci 9:144–156.
Dahme M, Bartsch U, Martini R, Anliker B, Schachner M, Mantei N
(1997) Disruption of the mouse L1 gene leads to malformations of the
nervous system. Nat Genet 17:346–349.
Damke H, Baba T, Warnock DE, Schmid SL (1994) Induction of mutant
dynamin specifically blocks endocytic coated vesicle formation. J Cell
Biol 127:915–934.
Davis JQ, Bennett V (1994) Ankyrin binding activity shared by the
neurofascin/L1/NrCAM family of cell adhesion molecules. J Biol
Chem 269:27163–27166.
Della Rocca GJ, Mukhin YV, Garnovskaya MN, Daaka Y, Clark GJ,
Luttrell LM, Lefkowitz RJ, Raymond JR (1999) Serotonin 5-HT1A
receptor-mediated Erk activation requires calcium/calmodulin-
dependent receptor endocytosis. J Biol Chem 274:4749–4753.
Demyanenko G, Tsai A, Maness PF (1999) Abnormalities in neuronal
process extension, hippocampal development, and the ventricular sys-
tem of L1 knockout mice. J Neurosci 19:4907–4920.
English JD, Sweatt JD (1996) Activation of p42 mitogen-activated pro-
tein kinase in hippocampal long term potentiation. J Biol Chem
271:24329–24332.
English JD, Sweatt JD (1997) A requirement for the mitogen-activated
protein kinase cascade in hippocampal long term potentiation. J Biol
Chem 272:19103–19106.
Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser
WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA,
Magolda RL, Scherle PA, Trzaskos JM (1998) Identification of a
novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem
273:18623–18632.
Fransen E, VanCamp G, Vits L, Willems PJ (1997) L1-associated dis-
eases: clinical geneticists divide, molecular geneticists unite. Hum Mol
Genet 6:1625–1632.
Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE, Cobb MH
(1997) Cross-cascade activation of ERKs and ternary complex factors
by Rho family proteins. EMBO J 16:6426–6438.
Fucini RV, Okada S, Pessin JE (1999) Insulin-induced desensitization of
extracellular signal-regulated kinase activation results from an inhibi-
tion of Raf activity independent of Ras activation and dissociation of
the Grb2-SOS complex. J Biol Chem 274:18651–18658.
Fuller SJ, Davies EL, Gillespie-Brown J, Sun H, Tonks NK (1997)
Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation
of gene expression by hypertrophic agonists in cardiac myocytes. Bio-
chem J 323:313–319.
Ginty DD, Bonni A, Greenberg ME (1994) Nerve growth factor acti-
vates a Ras-dependent protein kinase that stimulates c-fos transcription
via phosphorylation of CREB. Cell 77:713–725.
Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD, Krishna UM,
Falck JR, White MA, Broek D (1998) Role of substrates and products
of PI 3-kinase in regulating activation of Rac-related guanosine triphos-
phatases by Vav. Science 279:558–560.
Haney CA, Sahenk Z, Li C, Lemmon VP, Roder J, Trapp BD (1999)
Heterophilic binding of L1 on unmyelinated sensory axons mediates
Schwann cell adhesion and is required for axonal survival. J Cell Biol
146:1173–1184.
Hara K, Yonezawa K, Sakaue H, Ando A, Kotani K, Kitamura T,
Kitamura Y, Ueda H, Stephens L, Jackson TR, Waterfield MD, Kaskga
M (1994) 1-Phosphatidylinositol 3-kinase activity is required for
insulin-stimulated glucose transport but not for RAS activation in
CHO cells. Proc Natl Acad Sci USA 91:7415–7419.
Heldin CH (1995) Dimerization of cell surface receptors in signal trans-
duction. Cell 80:213–223.
Hinshaw JE, Schmid SL (1995) Dynamin self-assembles into rings sug-
gesting a mechanism for coated vesicle budding. Nature 374:190–192.
Hong K, Hinck L, Nishiyama M, Poo MM, Tessier-Lavigne M, Stein E
(1999) A ligand-gated association between cytoplasmic domains of
UNC5 and DCC family receptors converts netrin-induced growth cone
attraction to repulsion. Cell 97:927–941.
Howe AK, Juliano RL (1998) Distinct mechanisms mediate the initial and
sustained phases of integrin-mediated activation of the Raf/MEK/
mitogen-activated protein kinase cascade. J Biol Chem 273:27268–27274.
Hulley P, Schachner M, Lubbert H (1998) L1 neural cell adhesion mol-
ecule is a survival factor for fetal dopaminergic neurons. J Neurosci Res
53:129–134.
Ignelzi MA, Miller DR, Soriano P, Maness PF (1994) Impaired neurite
outgrowth of src-minus cerebellar neurons on the cell adhesion mole-
cule L1. Neuron 12:873–884.
Ihara S, Nakajima K, Fukada T, Hibi M, Ngata S, Hirano T, Fukui Y
(1997) Dual control of neurite outgrowth by STAT3 and MAP kinase
in PC12 cells stimulated by interleukin-6. EMBO J 16:5345–5352.
Kamiguchi H, Lemmon V (1998) A neuronal form of the cell adhesion
molecule L1 contains a tyrosine-based signal required for sorting to the
axonal growth cone. J Neurosci 18:3749–3756.
Kamiguchi H, Long KE, Pendergast M, Schaefer AW, Rapoport I,
Kirchhausen T, Lemmon V (1998) The neural cell adhesion molecule
L1 interacts with the AP-2 adaptor and is endocytosed via the clathrin-
mediated pathway. J Neurosci 18:5311–5321.
Klinz SG, Schachner M, Maness PF (1995) L1 and NCAM antibodies
trigger protein phosphatase activity in growth cone-enriched mem-
branes. J Neurochem 65:84–95.
Koch WJ, Hawes BE, Allen LF, Lefkowitz RJ (1994) Direct evidence
that Gi-coupled receptor stimulation of mitogen-activated protein ki-
nase is mediated by G beta gamma activation of p21ras. Proc Natl Acad
Sci USA 91:12706–12710.
Kozma R, Sarner S, Ahmed S, Lim L (1997) Rho family GTPases and
neuronal growth cone remodelling: relationship between increased
complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse
induced by RhoA and lysophosphatidic acid. Mol Cell Biol
17:1201–1211.
Lamaze C, Chuang TH, Terlecky LJ, Bokoch GM, Schmid SL (1996)
Regulation of receptor-mediated endocytosis by Rho and Rac. Nature
382:177–179.
Lin TH, Aplin AE, Shen Y, Chen Q, Schaller M, Romer L, Aukhil I,
Juliano RL (1997) Integrin-mediated activation of MAP kinase is
independent of FAK: evidence for dual integrin signaling pathways in
fibroblasts. J Cell Biol 136:1385–1395.
Luthi A, Laurent JP, Figurov A, Muller D, Schachner M (1994) Hip-
pocampal long-term potentiation and neural cell adhesion molecules L1
and NCAM. Nature 372:777–779.
Luttrell LM, Daaka Y, Della Rocca GJ, Lefkowitz RJ (1997) G protein-
coupled receptors mediate two functionally distinct pathways of ty-
rosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and
receptor endocytosis correlate with activation of Erk kinases. J Biol
Chem 272:31648–31656.
Madhani HD, Styles CA, Fink GR (1997) MAP kinases with distinct
Schmid et al. • L1/MAPK Mediates Neurite Growth by Src-Regulated Endocytosis J. Neurosci., June 1, 2000, 20(11):4177–4188 4187
inhibitory functions impart signaling specificity during yeast differen-
tiation. Cell 91:673–684.
Maness PF, Beggs HE, Klinz SG, Morse WR (1996) Selective neural
cell adhesion molecule signaling by src family tyrosine kinases and
phosphatases. Perspect Dev Neurobiol 4:169–181.
Marais R, Wynne J, Treisman R (1993) The SRF accessory protein
Elk-1 contains a growth factor-regulated transcriptional activation do-
main. Cell 73:381–393.
Marshall CJ (1994) MAP kinase kinase kinase, MAP kinase kinase and
MAP kinase. Curr Opin Genet Dev 4:82–89.
Michael D, Martin KC, Seger R, Ning MM, Baston R, Kandel ER (1998)
Repeated pulses of serotonin required for long-term facilitation acti-
vate mitogen-activated protein kinase in sensory neurons of Aplysia.
Proc Natl Acad Sci USA 95:1864–1869.
Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ (1998) Iden-
tification of a novel integrin signaling pathway involving the kinase Syk
and the guanine nucleotide exchange factor Vav1. Curr Biol
8:1289–1299.
Montgomery AMP, Becker JC, Siu C, Lemmon VP, Cheresh DA, Pan-
cook JD, Zhao X, Reisfeld RA (1996) Human neural cell adhesion
molecule L1 and rat homologue NILE are ligands for integrin_v_3.
J Cell Biol 132:475–485.
Myers Jr MG, Sun XJ, Cheatham B, Jachna BR, Glasheen EM, Backer
JM, White MF (1993) IRS-1 is a common element in insulin and
insulin-like growth factor-I signaling to the phosphatidylinositol 39-
kinase. Endocrinology 132:1421–1430.
Nave BT, Siddle K, Shepherd PR (1996) Phorbol esters stimulate phos-
phatidylinositol 3,4,5-trisphosphate production in 3T3–L1 adipocytes:
implications for stimulation of glucose transport. Biochem J
318:203–205.
Nimnual AS, Yatsula BA, Bar-Sagi D (1998) Coupling of Ras and Rac
guanosine triphosphatases through the Ras exchanger Sos. Science
279:560–563.
Nobes CD, Hall A (1995) Rho, rac and cdc42 GTPases: regulators of
actin structures, cell adhesion and motility. Biochem Soc Trans
23:456–459.
Payne HR, Burden SM, Lemmon V (1992) Modulation of growth cone
morphology by substrate-bound adhesion molecules. Cell Motil Cy-
toskeleton 21:65–73.
Persohn E, Schachner M (1990) Immunohistological localization of the
neural cell adhesion molecule L1 and NCAM in the developing hip-
pocampus of the mouse. J Neurocytol 19:807–819.
Ponniah S, Wang DZ, Lim KL, Pallen CJ (1999) Targeted disruption of
the tyrosine phosphatase PTPalpha leads to constitutive downregula-
tion of the kinases Src and Fyn. Curr Biol 9:535–538.
Quilliam LA, Kato K, Rabun KM, Hisaka MM, Huff SY, Campbell-Burk
S, Der CJ (1994) Identification of residues critical for Ras(17N)
growth-inhibitory phenotype and for Ras interaction with guanine
nucleotide exchange factors. Mol Cell Biol 14:1113–1121.
Quilliam LA, Khosravi-Far R, Huff SY, Der CJ (1995) Guanine nucle-
otide exchange factors: activators of the Ras superfamily of proteins.
BioEssays 17:395–404.
Riccio A, Pierchala BA, Ciarallom CL, Ginty DD (1997) An NGF-
TrkA-mediated retrograde signal to transcription factor CREB in sym-
pathetic neurons. Science 277:1097–1100.
Richardson A, Parsons T (1996) A mechanism for regulation of the
adhesion-associated protein tyrosine kinase pp125FAK. Nature
380:538–540.
Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The
small GTP-binding protein rac regulates growth factor-induced mem-
brane ruffling. Cell 70:401–410.
Saffell JL, Williams EJ, Mason IJ, Walsh FS, Doherty P (1997) Expres-
sion of a dominant negative FGF receptor inhibits axonal growth and
FGF receptor phosphorylation stimulated by CAMs. Neuron
18:231–242.
Schaefer AW, Kamiguchi H, Wong EV, Beach CM, Landreth G, Lem-
mon V (1999) Activation of the MAPK signal cascade by the neural
cell adhesion molecule L1 requires L1 internalization. J Biol Chem
274:37965–37973.
Schaller MD, Borgman CA, Parsons JT (1993) Autonomous expression
of a noncatalytic domain of the focal adhesion-associated protein ty-
rosine kinase pp125FAK. Mol Cell Biol 13:785–791.
Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons
JT (1994) Autophosphorylation of the focal adhesion kinase,
pp125 FAK, directs SH2-dependent binding of pp60 src. Mol Cell Biol
14:1680–1688.
Schlaepfer DD, Hunter T (1997) Focal adhesion kinase overexpression
enhances ras-dependent integrin signaling to ERK2/mitogen-activated
protein kinase through interaction with and activation of c-Src. J Biol
Chem 272:13189–13195.
Schmid R-S, Maness PF (2000) Cell recognition molecules and disorders
of neurodevelopment. In: International handbook on brain and behav-
iour in human development (Kalverboer AF, Gramsbergen A, eds).
Groningen, The Netherlands: Academic, in press.
Schmid R-S, Hemperly JJ, Schaller MD, Maness PF (1997) NCAM and
L1 cell adhesion molecules activate MAP kinase signaling pathways.
Soc Neurosci Abstr 23:767.6.
Schmid R-S, Graff R, Schaller MD, Chen S, Schachner M, Hemprily JJ,
Maness PF (1999) NCAM stimulates the Ras-MAPK pathway and
CREB phosphorylation in neuronal cells. J Neurobiol 38:542–555.
Schnitzer J, Schachner M (1981) Characterization of isolated mouse
cerebellar cell populations in vitro. J Neuroimmunol 1:457–470.
Scholey AB, Rose SP, Zamani MR, Bock E, Schachner M (1993) A role
for the neural cell adhesion molecule in a late, consolidating phase of
glycoprotein synthesis six hours following passive avoidance training of
the young chick. Neuroscience 55:499–509.
Schubert D, Heinemann S, Carlisle W, Tarikas H, Kimes B, Patrick J,
Steinback JH, Culp W, Brandt BL (1974) Clonal cell lines from the rat
central nervous system. Nature 249:224–227.
Schuch U, Lohse MJ, Schachner M (1989) Neural cell adhesion mole-
cules influence second messenger systems. Neuron 3:13–20.
Sumi T, Matsumoto K, Takai Y, Nakamura T (1999) Cofilin phosphor-
ylation and actin cytoskeletal dynamics regulated by Rho- and Cdc42-
activated LIM-kinase 2. J Cell Biol 147:1519–1532.
Twamley-Stein GM, Pepperkok R, Ansorge W, Courtneidge SA (1993)
The Src family tyrosine kinases are required for platelet-derived
growth factor-mediated signal transduction in NIH 3T3 cells. Proc Natl
Acad Sci USA 90:7696–7700.
Vieira AV, Lamaze C, Schmid SL (1996) Control of EGF receptor
signaling by clathrin-mediated endocytosis. Science 274:2086–2089.
Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor
of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-
benzopyran-4-one (LY294002). J Biol Chem 269:5241–5248.
Vojtek AB, Cooper JA (1995) Rho family members: activators of MAP
kinase cascades. Cell 82:527–529.
von Bohlen und Halbach F, Taylor J, Schachner M (1992) Cell type-
specific effects of the neural adhesion molecules L1 and N-CAM on
diverse second messenger systems. Eur J Neurosci 4:896–909.
Waskiewicz AJ, Cooper JA (1995) Mitogen and stress response path-
ways: MAP kinase cascades and phosphatase regulation in mammals
and yeast. Curr Opin Cell Biol 7:798–805.
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Op-
posing effects of ERK and JNK-p38 MAP kinases on apoptosis. Sci-
ence 270:1326–1331.
Yang N, Higuchi O, Ohashi K, Nagata K, Wada A, Kangawa K, Nishida
E, Mizuno K (1998) Cofilin phosphorylation by LIM-kinase 1 and its
role in Rac-mediated actin reorganization. Nature 393:809–812.
Yip PM, Zhao X, Montgomery AM, Siu CH (1998) The Arg-Gly-Asp
motif in the cell adhesion molecule L1 promotes neurite outgrowth via
interaction with the alphavbeta3 integrin. Mol Biol Cell 9:277–290.
Zhao X, Yip PM, Siu CH (1998) Identification of a homophilic binding
site in immunoglobulin-like domain 2 of the cell adhesion molecule L1.
J Neurochem 71:960–971.
4188 J. Neurosci., June 1, 2000, 20(11):4177–4188 Schmid et al. • L1/MAPK Mediates Neurite Growth by Src-Regulated Endocytosis
